🔎 Trials Near Me

Utama › Keletihan › Pennsylvania

Kajian klinikal Keletihan di Pennsylvania

6 kajian untuk Keletihan sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

Natural History Study of Mitochondrial Myopathy

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 0 hingga 100 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05250375

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

  • Abington Neurological Associates, Abington
  • Suburban Research Associates, West Chester
  • Berks Schuylkill Respiratory Specialists, Wyomissing
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07500090

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  • Alkermes Investigational Site, Wyomissing
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07455383

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  • Abington Neurological Associates, Abington
  • Geisinger Medical Center, Danville
  • University of Pittsburgh, Pittsburgh
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07675135

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

  • University of Pittsburgh, Pittsburgh
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06978127

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

  • University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jan 2026 · NCT06675344

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.